Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 3
2012 1
2013 4
2014 3
2015 6
2016 2
2017 6
2018 3
2019 5
2020 4
2021 7
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.
Luna-Gutiérrez M, Hernández-Ramírez R, Soto-Abundiz A, García-Pérez O, Ancira-Cortez A, López-Buenrostro S, Gibbens-Bandala B, Soldevilla-Gallardo I, Lara-Almazán N, Rojas-Pérez M, Ocampo-García B, Azorín-Vega E, Santos-Cuevas C, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: santos cuevas c. Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988. Pharmaceutics. 2023. PMID: 37514174 Free PMC article.
[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging.
Rivera-Bravo B, Ramírez-Nava G, Mendoza-Figueroa MJ, Ocampo-García B, Ferro-Flores G, Ávila-Rodríguez MA, Santos-Cuevas C. Rivera-Bravo B, et al. Among authors: santos cuevas c. Nucl Med Biol. 2021 May-Jun;96-97:54-60. doi: 10.1016/j.nucmedbio.2021.03.005. Epub 2021 Mar 27. Nucl Med Biol. 2021. PMID: 33831746
Toxicity Assessment of [177Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes.
Hernández-Jiménez T, Cruz-Nova P, Ancira-Cortez A, Gibbens-Bandala B, Lara-Almazán N, Ocampo-García B, Santos-Cuevas C, Morales-Avila E, Ferro-Flores G. Hernández-Jiménez T, et al. Among authors: santos cuevas c. Nanomaterials (Basel). 2022 Nov 25;12(23):4181. doi: 10.3390/nano12234181. Nanomaterials (Basel). 2022. PMID: 36500804 Free PMC article.
Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications.
Aranda-Lara L, Isaac-Olivé K, Ocampo-García B, Ferro-Flores G, González-Romero C, Mercado-López A, García-Marín R, Santos-Cuevas C, Estrada JA, Morales-Avila E. Aranda-Lara L, et al. Among authors: santos cuevas c. Molecules. 2022 Oct 19;27(20):7046. doi: 10.3390/molecules27207046. Molecules. 2022. PMID: 36296638 Free PMC article.
Targeted photodynamic therapy using reconstituted high-density lipoproteins as rhodamine transporters.
Ávila-Sánchez MA, Isaac-Olivé K, Aranda-Lara L, Morales-Ávila E, Plata-Becerril A, Jiménez-Mancilla NP, Ocampo-García B, Estrada JA, Santos-Cuevas CL, Torres-García E, Camacho-López MA. Ávila-Sánchez MA, et al. Among authors: santos cuevas cl. Photodiagnosis Photodyn Ther. 2022 Mar;37:102630. doi: 10.1016/j.pdpdt.2021.102630. Epub 2021 Nov 17. Photodiagnosis Photodyn Ther. 2022. PMID: 34798347
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.
Ocampo-García B, Cruz-Nova P, Jiménez-Mancilla N, Luna-Gutiérrez M, Oros-Pantoja R, Lara-Almazán N, Pérez-Velasco D, Santos-Cuevas C, Ferro-Flores G. Ocampo-García B, et al. Among authors: santos cuevas c. Int J Mol Sci. 2023 Nov 21;24(23):16553. doi: 10.3390/ijms242316553. Int J Mol Sci. 2023. PMID: 38068876 Free PMC article.
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.
Ferro-Flores G, Ocampo-García B, Cruz-Nova P, Luna-Gutiérrez M, Bravo-Villegas G, Azorín-Vega E, Jiménez-Mancilla N, Michel-Sánchez E, García-Pérez O, Lara-Almazán N, Santos-Cuevas C. Ferro-Flores G, et al. Among authors: santos cuevas c. Pharmaceutics. 2023 Nov 23;15(12):2662. doi: 10.3390/pharmaceutics15122662. Pharmaceutics. 2023. PMID: 38140003 Free PMC article.
225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins.
Hernández-Jiménez T, Ferro-Flores G, Morales-Ávila E, Isaac-Olivé K, Ocampo-García B, Aranda-Lara L, Santos-Cuevas C, Luna-Gutiérrez M, De Nardo L, Rosato A, Meléndez-Alafort L. Hernández-Jiménez T, et al. Among authors: santos cuevas c. Molecules. 2022 Mar 27;27(7):2156. doi: 10.3390/molecules27072156. Molecules. 2022. PMID: 35408554 Free PMC article.
57 results